S. Shorakae

发表

The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome

B. de Courten, H. Teede, N. Naderpoor, 2020, Nutrients.

Assessment and Management of Women with Polycystic Ovary Syndrome (PCOS)

H. Teede, R. Garad, S. Shorakae, 2019, Advanced Practice in Endocrinology Nursing.

High-molecular-weight adiponectin is inversely associated with sympathetic activity in polycystic ovary syndrome.

B. de Courten, H. Teede, G. Lambert, 2018, Fertility and sterility.

Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance

B. Courten, L. Moran, H. Teede, 2017, The Journal of Steroid Biochemistry and Molecular Biology.

The importance of screening for diabetes in women with polycystic ovary syndrome

H. Teede, A. Joham, S. Shorakae, 2015 .

Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about

H. Teede, J. Boyle, S. Shorakae, 2014, Internal medicine journal.

Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance

B. de Courten, J. Dixon, H. Teede, 2015, Clinical endocrinology.

Relationship between vitamin D and gestational diabetes in overweight or obese pregnant women may be mediated by adiponectin.

B. de Courten, H. Teede, A. Mousa, 2017, Molecular nutrition & food research.

A rare cause of hypoactive delirium

A. Amiruddin, S. Shorakae, S. Kosari, 2014, BMJ Case Reports.

The Emerging Role of Chronic Low-Grade Inflammation in the Pathophysiology of Polycystic Ovary Syndrome

L. Moran, B. de Courten, H. Teede, 2015, Seminars in Reproductive Medicine.

Brown adipose tissue thermogenesis in polycystic ovary syndrome

B. de Courten, H. Teede, I. Clarke, 2018, Clinical endocrinology.

Title : The association between dysregulated adipocytokines in early pregnancy and development of Gestational Diabetes Short title : Adipocytokines in gestational diabetes

B. Courten, H. Teede, C. Harrison, 2017 .

The association between dysregulated adipocytokines in early pregnancy and development of gestational diabetes

B. de Courten, H. Teede, C. Harrison, 2017, Diabetes/metabolism research and reviews.

Obesity and polycystic ovary syndrome.

B. de Courten, H. Teede, A. Joham, 2015, Minerva endocrinologica.

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.

L. Moran, B. de Courten, H. Teede, 2015, Human reproduction update.

B. de Courten, H. Teede, G. Lambert, 2018, Clinical endocrinology.

Congenital adrenal hyperplasia and pregnancy

H. Teede, S. Shorakae, 2013, BMJ Case Reports.

Does moxonidine reduce Achilles tendon or musculoskeletal pain in women with polycystic ovarian syndrome? A secondary analysis of a randomised controlled trial

G. Lambert, E. Lambert, J. Gaida, 2020, BMC Endocrine Disorders.

Efficacy of predictive models for polycystic ovary syndrome using serum levels of two antimüllerian hormone isoforms (proAMH and AMHN,C).

L. Moran, H. Teede, R. Rodgers, 2017, Fertility and sterility.

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.

L. Moran, B. de Courten, H. Teede, 2015, Human reproduction update.

High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial.

A. Garnham, A. McAinch, A. Parker, 2022, Human reproduction.

Abstracts of the Endocrine Society of Australia's Annual Scientific Meeting 2017.

Helena, L. Moran, H. Teede, 2018, Clinical endocrinology.

The Role of Lifestyle Intervention in the Prevention and Treatment of Gestational Diabetes

W. Brown, C. Harrison, T. Moholdt, 2020, Seminars in Reproductive Medicine.

Role of serum biomarkers to optimise a validated clinical risk prediction tool for gestational diabetes

B. de Courten, H. Teede, C. Harrison, 2018, The Australian & New Zealand journal of obstetrics & gynaecology.

Effect of Central Sympathoinhibition With Moxonidine on Sympathetic Nervous Activity in Polycystic Ovary Syndrome—A Randomized Controlled Trial

B. de Courten, J. Dixon, H. Teede, 2018, Front. Physiol..

The effectiveness of high intensity intermittent training on metabolic, reproductive and mental health in women with polycystic ovary syndrome: study protocol for the iHIT- randomised controlled trial

L. Moran, A. Joham, C. Harrison, 2019, Trials.

Reply: Metformin for women with hyperandrogenic anovulation.

L. Moran, B. de Courten, H. Teede, 2016, Human reproduction update.

The Emerging Role of Chronic Low-Grade Inflammation in the Pathophysiology of Polycystic Ovary Syndrome

L. Moran, B. de Courten, H. Teede, 2015, Seminars in Reproductive Medicine.

Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers--a molecular study of 59 patients.

M. Mohagheghi, S. Ghaffari, A. Mosavi-Jarrahi, 2006, Asian Pacific journal of cancer prevention : APJCP.

Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

T. Piltonen, C. Tay, C. Harrison, 2024, Nature communications.

Systematic review and meta-analysis of birth outcomes in women with polycystic ovary syndrome

T. Piltonen, C. Tay, C. Harrison, 2024, Nature communications.